文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

一种新开发的用于保存粪便标本中短链脂肪酸、胆汁酸和微生物群的溶液。

A newly developed solution for the preservation of short-chain fatty acids, bile acids, and microbiota in fecal specimens.

作者信息

Takagi Tomohisa, Kunihiro Tadao, Takahashi Shunsuke, Hisada Takayoshi, Nagashima Koji, Mochizuki Jun, Mizushima Katsura, Naito Yuji

机构信息

Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto 602-8566, Japan.

Department for Medical Innovation and Translational Medical Science, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto 602-8566, Japan.

出版信息

J Clin Biochem Nutr. 2023 May;72(3):263-269. doi: 10.3164/jcbn.22-107. Epub 2023 Feb 14.


DOI:10.3164/jcbn.22-107
PMID:37251966
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10209596/
Abstract

Recent studies have revealed that the gut microbiome affects various health conditions via its metabolites, including short-chain fatty acids (SCFAs) and bile acids (BAs). In the analysis of these, appropriate collection, handling, and storage of fecal specimens are required, and convenient specimen handling processes will facilitate their investigation. Here, we developed a novel preservation solution, "Metabolokeeper", to stabilize fecal microbiota, organic acids including SCFAs, and BAs at room temperature. In the present study, we collected fecal samples from 20 healthy adult volunteers and stored them at room temperature with Metabolokeeper and at -80°C without preservatives for up to four weeks to evaluate the usefulness of the novel preservative solution. We found that microbiome profiles and short chain fatty acid contents were stably maintained at room temperature with Metabolokeeper for 28 days, while the bile acids were stably maintained for 7 days under the same conditions. We conclude that this convenient procedure to obtain a fecal sample for collecting the gut microbiome and gut metabolites can contribute to a better understanding of the health effects of fecal metabolites produced by the gut microbiome.

摘要

最近的研究表明,肠道微生物群通过其代谢产物影响各种健康状况,包括短链脂肪酸(SCFAs)和胆汁酸(BAs)。在对这些物质的分析中,需要对粪便标本进行适当的采集、处理和储存,便捷的标本处理流程将有助于对它们的研究。在此,我们开发了一种新型保存溶液“Metabolokeeper”,用于在室温下稳定粪便微生物群、包括SCFAs在内的有机酸以及BAs。在本研究中,我们从20名健康成年志愿者身上采集粪便样本,并将其分别用Metabolokeeper在室温下保存以及在-80°C无防腐剂条件下保存长达四周,以评估这种新型保存溶液的效用。我们发现,使用Metabolokeeper在室温下,微生物群谱和短链脂肪酸含量可稳定保持28天,而在相同条件下胆汁酸可稳定保持7天。我们得出结论,这种获取用于收集肠道微生物群和肠道代谢产物的粪便样本的便捷程序,有助于更好地理解肠道微生物群产生的粪便代谢产物对健康的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d6/10209596/7b87c1af80f0/jcbn22-107f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d6/10209596/4b5698e9bb14/jcbn22-107f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d6/10209596/0f51f31a5f0b/jcbn22-107f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d6/10209596/31648c5ddb65/jcbn22-107f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d6/10209596/7b87c1af80f0/jcbn22-107f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d6/10209596/4b5698e9bb14/jcbn22-107f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d6/10209596/0f51f31a5f0b/jcbn22-107f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d6/10209596/31648c5ddb65/jcbn22-107f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d6/10209596/7b87c1af80f0/jcbn22-107f04.jpg

相似文献

[1]
A newly developed solution for the preservation of short-chain fatty acids, bile acids, and microbiota in fecal specimens.

J Clin Biochem Nutr. 2023-5

[2]
Changes in microbiome and metabolomic profiles of fecal samples stored with stabilizing solution at room temperature: a pilot study.

Sci Rep. 2020-2-4

[3]
Comparative Metabolomics and Microbiome Analysis of Ethanol versus OMNImet/gene•GUT Fecal Stabilization.

Anal Chem. 2024-6-4

[4]
Evaluation and Optimization of Sample Handling Methods for Quantification of Short-Chain Fatty Acids in Human Fecal Samples by GC-MS.

J Proteome Res. 2019-4-1

[5]
Microbiome-Metabolomics Analysis of the Impacts of Infection in BALB/C Mice.

Microbiol Spectr. 2023-2-14

[6]
[Variations of gut microbiome composition under different preservation solutions and periods].

Sheng Wu Gong Cheng Xue Bao. 2020-12-25

[7]
Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota.

Diabetes Res Clin Pract. 2020-11

[8]
Associations of gut microbiota, dietary intake, and serum short-chain fatty acids with fecal short-chain fatty acids.

Biosci Microbiota Food Health. 2020

[9]
Matrix Effects on the Delivery Efficacy of Bifidobacterium animalis subsp. BB-12 on Fecal Microbiota, Gut Transit Time, and Short-Chain Fatty Acids in Healthy Young Adults.

mSphere. 2021-8-25

[10]
Comparative methods for fecal sample storage to preserve gut microbial structure and function in an in vitro model of the human colon.

Appl Microbiol Biotechnol. 2020-12

引用本文的文献

[1]
Circuit training intervention for cognitive function, gut microbiota, and aging control: study protocol for a longitudinal, open-label randomized controlled trial.

Trials. 2025-3-18

[2]
Evaluation of solutions for stabilizing feces in metabolomics studies using GC × GC-TOFMS.

Metabolomics. 2025-2-21

[3]
Optimised human stool sample collection for multi-omic microbiota analysis.

Sci Rep. 2024-7-22

[4]
Effect of Intake on Blood Pressure and Gut Microbiota Composition in Spontaneously Hypertensive Rats.

Microorganisms. 2024-3-11

[5]
Relationship Between the Frequency of Bowel Movements and Fecal Bacteroides in Japanese Women.

Plant Foods Hum Nutr. 2024-6

[6]
The Networked Interaction between Probiotics and Intestine in Health and Disease: A Promising Success Story.

Microorganisms. 2024-1-18

[7]
Association between physical activity and the prevalence of tumorigenic bacteria in the gut microbiota of Japanese adults: a cross-sectional study.

Sci Rep. 2023-11-27

本文引用的文献

[1]
Changes in the Gut Microbiota are Associated with Hypertension, Hyperlipidemia, and Type 2 Diabetes Mellitus in Japanese Subjects.

Nutrients. 2020-9-30

[2]
The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome.

Nutrients. 2020-4-16

[3]
Changes in microbiome and metabolomic profiles of fecal samples stored with stabilizing solution at room temperature: a pilot study.

Sci Rep. 2020-2-4

[4]
Gut microbiota differences in elderly subjects between rural city Kyotango and urban city Kyoto: an age-gender-matched study.

J Clin Biochem Nutr. 2019-9

[5]
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2.

Nat Biotechnol. 2019-8

[6]
Effect of storage and DNA extraction method on 16S rRNA-profiled fecal microbiota in Japanese adults.

J Clin Biochem Nutr. 2019-3

[7]
Comparison of Fecal Collection Methods for Microbiome and Metabolomics Studies.

Front Cell Infect Microbiol. 2018-8-28

[8]
Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects.

J Gastroenterol. 2018-6-20

[9]
Methodology challenges in studying human gut microbiota - effects of collection, storage, DNA extraction and next generation sequencing technologies.

Sci Rep. 2018-3-23

[10]
Method for preparing DNA from feces in guanidine thiocyanate solution affects 16S rRNA-based profiling of human microbiota diversity.

Sci Rep. 2017-6-28

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索